A college student gets over the flu, but two weeks later feels winded after climbing stairs and complains of abdominal pain.

Eculizumab, a monoclonal antibody, is indicated for the treatment of two rare and life-threatening conditions: Paroxysmal ...

Eculizumab biosimilar Elizaria demonstrates long-term safety and efficacy comparable with the reference product Soliris in ...

Analysts at Jefferies have previously said that iptacopan could hit $3.6 billion in peak annual sales if it gets approved for all its target indications, which along with PNH include atypical ...

PNH is a rare, life-threatening disease of the blood characterised by destruction of red blood cells, blood clots and impaired bone marrow function, causing fatigue, recurrent infections and ...

AstraZeneca Pharma India rose 1.10% to Rs 10,754 after the firm received approval from the Central Drugs Standard Control Organisation (CDSCO) to import pharmaceutical formulations of eculizumab ...

A decision to approve new medicines to treat Duchenne muscular dystrophy and a rare life-threatening blood disease for use in NHS Scotland has ...

Eculizumab is used to treat paroxysmal nocturnal hemoglobinuria (PNH), a rare bone marrow disorder in which expansion of certain hematopoietic cells that lack a key protein cause the destruction of ...

Blood contamination was attributed as the cause of abnormal CSF findings in 2/13 (15.4%) of these dogs (RBC 2920 with a TNCC of 8 cells/μl in one dog with a glioma and RBC 9280 with a TNCC of 7 in a ...

The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.

Royal Bank of Canada restated their sector perform rating on shares of Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) in ...